Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Porous-wall hollow glass microspheres as carriers for biomolecules

Patent ·
OSTI ID:1093547

The present invention includes compositions of porous-wall hollow glass microspheres and one or more biomolecules, wherein the one or more biomolecules are positioned within a void location within the hollow glass microsphere, and the use of such compositions for the diagnostic and/or therapeutic delivery of biomolecules.

Research Organization:
SRNL (Savannah River National Laboratory (formerly SRTC) (United States))
Sponsoring Organization:
USDOE
DOE Contract Number:
AC09-08SR22470
Assignee:
Georgia Health Sciences University Research Institute, Inc. (Augusta, GA); Savannah River Nuclear Solutions, LLC (Aiken, SC)
Patent Number(s):
8,535,725
Application Number:
13/349,792
OSTI ID:
1093547
Country of Publication:
United States
Language:
English

References (22)

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides journal May 2008
Novel RNA-based Strategies for Therapeutic Gene Silencing journal March 2010
Unresectable Chemorefractory Liver Metastases: Radioembolization with 90 Y Microspheres—Safety, Efficacy, and Survival journal May 2008
Stability engineering of antibody single-chain Fv fragments journal February 2001
Targeted drug delivery via folate receptors journal March 2008
Non-coding RNAs: regulators of disease: Non-coding RNAs: regulators of disease journal October 2009
E. coli expression of a soluble, active single-chain antibody variable fragment containing a nuclear localization signal journal August 2009
The Shape of Immunoglobulin G Molecules in Solution journal April 1972
Modification of the ionizing radiation response in living cells by an scFv against the DNA-dependent protein kinase journal October 2003
Small-interfering RNAs in the radar of the interferon system journal September 2003
Soluble receptors in human disease journal August 1998
RNAi‐based therapeutics–current status, challenges and prospects journal June 2009
Recent Developments of Biodegradable and Biocompatible Materials Based Micro/Nanoparticles for Delivering Macromolecular Therapeutics journal January 2009
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism journal April 2009
Antisense oligonucleotides to the epidermal growth factor receptor journal January 1999
Challenges to macromolecular drug delivery journal January 2007
Intraspinal microinjection of chondroitinase ABC following injury promotes axonal regeneration out of a peripheral nerve graft bridge journal May 2008
Antisense oligonucleotide—induced inhibition of adrenocorticotropic hormone release from cultured human corticotrophs journal August 1999
Agarose-Dextran Gels as Synthetic Analogs of Glomerular Basement Membrane: Water Permeability journal April 2002
Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications journal February 2010
RNAi mechanisms and applications journal April 2008
A universal strategy for stable intracellular antibodies journal August 2005